Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer
Clinical trial NCT03946969 · UNKNOWN
Trial details
- NCT number
- NCT03946969
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-09
- Primary completion
- 2021-11-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.